Sjögren's Syndrome

You have full text access to this OnlineOpen article

Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial†

  1. Frank P. Strietzel1,
  2. Gloria I. Lafaurie2,
  3. Gloria R. Bautista Mendoza2,
  4. Ivan Alajbeg3,
  5. Slavica Pejda3,
  6. Lea Vuletić3,
  7. Rubén Mantilla4,
  8. Denise P. Falcão5,
  9. Soraya C. Leal5,
  10. Ana C. Barreto Bezerra5,
  11. Simon D. Tran6,
  12. Henri A. Ménard7,
  13. Suguru Kimoto8,
  14. Shaoxia Pan9,
  15. Rafael A. Martín-Granizo10,
  16. M. Lourdes Maniegas Lozano10,
  17. Susan L. Zunt11,‡,
  18. Cheryl A. Krushinski11,
  19. Dario Melilli12,
  20. Giuseppina Campisi12,
  21. Carlo Paderni12,
  22. Sonia Dolce12,
  23. Juan F. Yepes13,
  24. Liselott Lindh14,
  25. Meltem Koray15,
  26. Gonca Mumcu16,
  27. Sharon Elad17,
  28. Itai Zeevi17,
  29. Beatriz C. Aldape Barrios18,
  30. Rodrigo M. López Sánchez18,
  31. Ben Z. Beiski19,§,
  32. Andy Wolff19,§,*,
  33. Yrjö T. Konttinen20

Article first published online: 28 DEC 2010

DOI: 10.1002/art.27766

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 63, Issue 1, pages 180–190, January 2011

Additional Information

How to Cite

Strietzel, F. P., Lafaurie, G. I., Mendoza, G. R. B., Alajbeg, I., Pejda, S., Vuletić, L., Mantilla, R., Falcão, D. P., Leal, S. C., Bezerra, A. C. B., Tran, S. D., Ménard, H. A., Kimoto, S., Pan, S., Martín-Granizo, R. A., Lozano, M. L. M., Zunt, S. L., Krushinski, C. A., Melilli, D., Campisi, G., Paderni, C., Dolce, S., Yepes, J. F., Lindh, L., Koray, M., Mumcu, G., Elad, S., Zeevi, I., Barrios, B. C. A., López Sánchez, R. M., Beiski, B. Z., Wolff, A. and Konttinen, Y. T. (2011), Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: A multicenter, randomized trial. Arthritis & Rheumatism, 63: 180–190. doi: 10.1002/art.27766

Author Information

  1. 1

    Charité Universitätsmedizin Berlin, Berlin, Germany

  2. 2

    Universidad El Bosque, Bogotá, Colombia

  3. 3

    University of Zagreb, Zagreb, Croatia

  4. 4

    Clínica de Artritis y Rehabilitación, Bogotá, Colombia

  5. 5

    Universidade de Brasilia, Brasilia, Brazil

  6. 6

    McGill University, Montreal, Quebec, Canada

  7. 7

    McGill University and McGill University Health Center, Montreal, Quebec, Canada

  8. 8

    Nihon University School of Dentistry at Mastudo, Mastudo, Japan

  9. 9

    Hospital of Stomatology and Peking University, Beijing, China

  10. 10

    Hospital Clínico San Carlos, Madrid, Spain

  11. 11

    Indiana University, Indianapolis

  12. 12

    Università di Palermo, Palermo, Italy

  13. 13

    University of Kentucky, Lexington

  14. 14

    Malmö University, Malmö, Sweden

  15. 15

    Istanbul University, Istanbul, Turkey

  16. 16

    University of Marmara, Istanbul, Turkey

  17. 17

    Hebrew University Hadassah School of Dental Medicine, Jerusalem, Israel

  18. 18

    Universidad Nacional Autónoma de Mexico, Mexico City, Mexico

  19. 19

    Saliwell Ltd., Harutzim, Israel

  20. 20

    Helsinki University Central Hospital, University of Helsinki, and ORTON Orthopaedic Hospital, Helsinki, and COXA Hospital for Joint Replacement, Tampere, Finland

  1. ‡

    Dr. Zunt served as principal investigator in a study funded by Parion Sciences.

  2. §

    Mr. Beiski and Dr. Wolff own stock in Saliwell Ltd. and hold patents as coinventors of intraoral electronic medical devices.

*Saliwell Ltd., 65 Hatamar Street, Harutzim 60917, Israel

  1. †

    ClinicalTrials.gov identifier: NCT00509808.

Publication History

  1. Issue published online: 28 DEC 2010
  2. Article first published online: 28 DEC 2010
  3. Accepted manuscript online: 29 SEP 2010 01:52PM EST
  4. Manuscript Accepted: 21 SEP 2010
  5. Manuscript Received: 14 APR 2010

Funded by

  • Canadian Institutes of Health Research to McGill University (CIHR Program to Stimulate International Research Initiatives)
  • Swedish Laryng Foundation to Malmö University
  • Academy of Finland
  • Finska Läkaresällskapet
  • Helsinki University Central Hospital
  • ORTON Foundation to the University of Helsinki. Saliwell Ltd. (Harutzim, Israel)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (178K)

REFERENCES

  • 1
    Sreebny LM, Valdini A. Xerostomia: a neglected symptom. Arch Intern Med 1987; 147: 1333–7.
  • 2
    Tabak LA, Levine MJ, Mandel ID, Ellison SA. Role of salivary mucins in the protection of the oral cavity. J Oral Pathol 1982; 11: 1–17.
    Direct Link:
  • 3
    Pedersen AM, Bardow A, Beier Jensen S, Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 2002; 8: 117–29.
    Direct Link:
  • 4
    Steller M, Chou L, Daniels TE. Electrical stimulation of salivary flow in patients with Sjögren's syndrome. J Dent Res 1988; 67: 1334–7.
  • 5
    Proctor GB, Carpenter GH. Regulation of salivary gland function by autonomic nerves. Auton Neurosci 2007; 133: 3–18.
  • 6
    Thelin WR, Brennan MT, Lockhart PB, Singh ML, Fox PC, Papas AS, et al. The oral mucosa as a therapeutic target for xerostomia. Oral Dis 2008; 14: 683–9.
    Direct Link:
  • 7
    Strietzel FP, Martin-Granizo R, Fedele S, Lo Russo L, Mignogna M, Reichart PA, et al. Electrostimulating device in the management of xerostomia. Oral Dis 2007; 13: 206–13.
    Direct Link:
  • 8
    Vitali CS, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554–8.
  • 9
    Fox PC, Atkinson JC, Macynski AA, Wolff A, Kung DS, Valdez IH, et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 1991; 151: 1149–52.
  • 10
    Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL III, Tran-Johnson TK, et al, for the P92-01 Study Group. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren's syndrome. Arch Intern Med 1999; 159: 174–81.
  • 11
    Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 2002; 46: 748–54.
    Direct Link:
  • 12
    Pai S, Ghezzi E, Ship J. Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 311–6.
  • 13
    Thomson WM, Chalmers JM, Spencer AJ, Williams SM. The xerostomia inventory: a multi-item approach to measuring dry mouth. Community Dent Health 1999; 16: 12–7.
  • 14
    Vissink A, Wolff A, Veerman ECI. Saliva collectors. In: WongDT, editor. Salivary diagnostics. Ames (IA): Wiley-Blackwell; 2008. p. 37–59.
  • 15
    Fox PC, Cummins MJ, Cummins JM. Use of orally administered anhydrous crystalline maltose for relief of dry mouth. J Altern Complement Med 2001; 7: 33–43.
  • 16
    Pocock SJ. Clinical trials: a practical approach. Chichester (UK): John Wiley & Sons, 1983.
  • 17
    Milliken GA, Johnson DE. Analysis of messy data. Vol. I: Designed experiments. 2nd ed. Boca Raton (FL): Chapman & Hall; 2009. p. 599–609.
  • 18
    Senn S. Cross-over trials in clinical research. 2nd ed. Chichester (UK): John Wiley & Sons; 2002.
  • 19
    Brown H, Prescott R. Applied mixed models in medicine. New York: John Wiley & Sons; 1999.
  • 20
    Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974; AC-19: 716–23.
  • 21
    Hochberg Y. Some conservative generalizations of the T-method in simultaneous inference. J Multivariate Anal 1974; 4: 224–34.
  • 22
    Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed models. Cary (NC): SAS Institute; 1996.
  • 23
    Jonsson R, Haga HJ, Gordon T. Sjögren's syndrome. In: KoopmanWJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Philadelphia: Lippincott Williams &Wilkins; 2001. p. 1736–8.
  • 24
    Brennan MT, Shariff G, Lockhart PB, Fox PC. Treatment of xerostomia: a systematic review of therapeutic trials. Dent Clin North Am 2002; 46: 847–56.
  • 25
    Thomson WM. Issues in the epidemiological investigation of dry mouth. Gerodontology 2005; 22: 65–76.
    Direct Link:
  • 26
    Eliasson L, Birkhed D, Carlen A. Feeling of dry mouth in relation to whole and minor gland saliva secretion rate. Arch Oral Biol 2009; 54: 263–7.
  • 27
    Von Bultzingslowen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103 Suppl: S57.e1–15.
  • 28
    Dawes C. Circadian rhythms in human salivary flow rate and composition. J Physiol 1972; 220: 529–45.
  • 29
    Wong RK, Jones GW, Sagar SM, Fargas-Babjak A, Whelan T. A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 472–80.
  • 30
    Talal N, Quinn JH, Daniels TE. The clinical effects of electrostimulation on salivary function of Sjögren's syndrome patients: a placebo controlled study. Rheumatol Int 1992; 12: 43–5.
  • 31
    Hargitai IA, Sherman RG, Strother JM. The effects of electrostimulation on parotid saliva flow: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 316–20.
  • 32
    Domingo DL. The effects of electrostimulation on saliva production in postradiation head and neck cancer patients [abstract]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 464.
  • 33
    Kiesselbach JE, Chamberlain JG. Clinical and anatomic observations on the relationship of the lingual nerve to the mandibular third molar region. J Oral Maxillofac Surg 1984; 42: 565–7
  • 34
    Pittman DW, Contreras RJ. Responses of single lingual nerve fibers to thermal and chemical stimulation. Brain Res 1998; 790: 224–35.
  • 35
    Eliav E, Gracely RC. Sensory changes in the territory of the lingual and inferior alveolar nerves following lower third molar extraction. Pain 1998; 77: 191–9.
  • 36
    Fall M, Lindstrom S. Functional electrical stimulation: physiological basis and clinical principles. Int Urogynecol J 1994; 5: 296–304.
  • 37
    Mansson B, Nilsson BO, Ekstrom J. Effects of repeated infusions of substance P and vasoactive intestinal peptide on the weights of salivary glands subjected to atrophying influences in rats. Br J Pharmacol 1990; 101: 853–8.
  • 38
    Ekstrom J, Reinhold AC. Influence of parasympathetic non-adrenergic, non-cholinergic mechanisms on [3H]thymidine uptake in rat parotid salivary glands in response to mastication following upon a liquid regimen. Arch Oral Biol 2001; 46: 1151–5.
  • 39
    Calafat M, Larocca L, Roca V, Hauk V, Pregi N, Nesse A, et al. Vasoactive intestinal peptide inhibits TNF-α-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands. Arthritis Res Ther 2009; 11: R53.
  • 40
    Thomson WM, Chalmers JM, Spencer AJ, Slade GD, Carter KD. A longitudinal study of medication exposure and xerostomia among older people. Gerodontology 2006; 23: 205–13.
    Direct Link:
  • 41
    Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 2010; 18: 1039–60.
  • 42
    Moutsopoulos HM. Sjögren's syndrome. In: SchumacherHR, KlippelJH, KoopmanWJ, editors. Primer on the rheumatic diseases. 10th ed. Atlanta: Arthritis Foundation; 1993. p. 131–5.
  • 43
    Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK. Neurobiological mechanisms of the placebo effect. J Neurosci 2005; 25: 10390–402.
View Full Article (HTML) Get PDF (178K)